Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel W Beenken

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 26, 2009
Treatment options for Merkel cell carcinomaSamuel W Beenken, Marshall M Urist
Surgery|December 12, 2003
Therapy for calciphylaxis: an outcome analysisJorge E Arch-Ferrer, Samuel W Beenken, Loring W Rue, et al.
Annals of Surgery|May 2, 2003
Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancerSamuel W Beenken, Marshall M Urist, Yuting Zhang, et al.
Journal of the American College of Surgeons|August 10, 2002
Transforming growth factor-alpha: a surrogate endpoint biomarker?Samuel W Beenken, Richard Hockett, William Grizzle, et al.
Annals of Surgery|May 30, 2002
Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancerHeriberto Medina-Franco, Luis O Vasconez, R Jobe Fix, et al.
Cancer Letters|October 29, 2003
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancersClinton J Grubbs, Donald L Hill, Kirby I Bland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulatorCarol J Fabian, Bruce F Kimler, Julie Anderson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|September 26, 2009
Treatment options for Merkel cell carcinomaSamuel W Beenken, Marshall M Urist
Surgery|December 12, 2003
Therapy for calciphylaxis: an outcome analysisJorge E Arch-Ferrer, Samuel W Beenken, Loring W Rue, et al.
Annals of Surgery|May 2, 2003
Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancerSamuel W Beenken, Marshall M Urist, Yuting Zhang, et al.
Journal of the American College of Surgeons|August 10, 2002
Transforming growth factor-alpha: a surrogate endpoint biomarker?Samuel W Beenken, Richard Hockett, William Grizzle, et al.
Annals of Surgery|May 30, 2002
Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancerHeriberto Medina-Franco, Luis O Vasconez, R Jobe Fix, et al.
Cancer Letters|October 29, 2003
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancersClinton J Grubbs, Donald L Hill, Kirby I Bland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulatorCarol J Fabian, Bruce F Kimler, Julie Anderson, et al.
Pageof 1